Stanford University
Showing 2,251-2,300 of 7,822 Results
-
Joseph Garner
Professor of Comparative Medicine and, by courtesy, of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsThe medical research community has long recognized that "good well-being is good science". The lab uses an integrated interdisciplinary approach to explore this interface, while providing tangible deliverables for the well-being of human patients and research animals.
-
Matthias Garten
Assistant Professor of Microbiology and Immunology and of Bioengineering
Current Research and Scholarly InterestsWith a creative, collaborative, biophysical mindset, we aim to understand the ability non-model organisms to interface with environment to a point at which we can exploit the mechanisms finding cures against diseases and use the mechanisms as tools that we can use to engineer the environment. By developing approaches that allow a quantitative understanding and manipulation of molecular transport our research makes non-model organisms accessible to researchers and engineers.
Specifically, we are studying how the malaria parasite takes control over red blood cells. By learning the biophysical principles of transport in between the host and the parasite we can design ways to kill the parasite or exploit it to reengineer red blood cells. The transport we study is broadly encompassing everything from ions to lipids and proteins. We use variations of quantitative microscopy and electrophysiology to gain insight into the unique strategies the parasite evolved to survive. -
Sergios Gatidis
Associate Professor of Radiology (Pediatric Radiology)
BioDr. Gatidis completed his medical training at the University of Tuebingen / Germany and received his Diploma in Mathematics from from the Universities of Tuebingen and Hagen / Germany. His research is focused on on methods and applications of machine learning for medical data analysis and translation of AI into clinical practice.
-
Brice Gaudilliere
Professor of Anesthesiology, Perioperative and Pain Medicine (MSD) and, by courtesy, of Pediatrics (Neonatology)
Current Research and Scholarly InterestsThe advent of high dimensional flow cytometry has revolutionized our ability to study and visualize the human immune system. Our group combines high parameter mass cytometry (a.k.a Cytometry by Time of Flight Mass Spectrometry, CyTOF), with advanced bio-computational methods to study how the human immune system responds and adapts to acute physiological perturbations. The laboratory currently focuses on two clinical scenarios: surgical trauma and pregnancy.
-
Dyani Gaudilliere
Clinical Associate Professor, Surgery - Plastic & Reconstructive Surgery
BioDr. Dyani Gaudilliere specializes in Dental Surgery and Oral Oncology in a hospital setting. As a hospital dentist she performs surgical treatment of infection and trauma to the teeth and supporting alveolar bone. She also performs medically necessary dental clearance and extractions in the context of larger medical conditions, such as cardiac disease, joint replacement, or organ transplantation. As an oral oncologist, she specializes in surgical dental treatment prior to, during, and following radiation therapy and chemotherapy.
-
Benny Gavi, MD, MTS
Clinical Assistant Professor, Medicine
Current Research and Scholarly InterestsHospitalist Medicine
Medicine Consultation
Quality Improvement
Medical Ethics
Organizational Ethics
Medical Humanities -
Charles Gawad
Associate Professor of Pediatrics (Hematology/Oncology)
BioOur lab works at the interface of biotechnology, computational biology, cellular biology, and clinical medicine to develop and apply new tools for characterizing genetic variation across single cells within a tissue with unparalleled sensitivity and accuracy. We are focused on applying these technologies to study cancer clonal evolution while patients are undergoing treatment with the aim of identifying cancer clonotypes that are associated with resistance to specific drugs so as to better understand and predict treatment response. We are also applying these methods to understand how more virulent pathogens emerge from a population of bacteria or viruses with an emphasis on developing a deeper understanding of how antibiotic resistance develops.
-
Michael W. Gaynon, MD
Clinical Professor, Ophthalmology
Current Research and Scholarly Interests-Retinal Vascular Disease
-Angiogenesis
-Retinopathy of Prematurity
-Sustained Release Drug Delivery Systems -
Sharon Markham Geaghan
Associate Professor of Pathology at the Stanford University Medical Center, Emerita
Current Research and Scholarly InterestsPediatric Hematopathology, Pediatric Laboratory Medicine and Pathology
-
Kristopher Geda (he/him)
Advanced Lecturer
BioI am the coordinator of English for Speakers of Other Languages in the Stanford Language Center. Additionally, I teach courses in academic writing, speaking, and listening to graduate students. I also teach a pedagogy and practicum class in the Division of Literatures, Cultures, and Languages for both undergraduate and graduate students who want to explore English language teaching in the future. My main areas of interest are writing, grammar, and extra-curricular communicative skills such as developing the cultural literacy to successfully write professional documents like cover letters, CVs, and resumes, as well as interact socially in professional and personal environments. I speak Spanish and French well, and a little bit of Mandarin and Esperanto.
-
Hester Gelber
Professor of Religious Studies and, by courtesy, of German Studies, Emerita
BioHester Gelber specializes in late medieval religious thought. She has taught courses on philosophy of religion as well as medieval Christianity. She has written extensively on medieval Dominicans, including: Exploring the Boundaries of Reason: Three Questions on the Nature of God by Robert Holcot OP and most recently It Could Have Been Otherwise: Contingency and Necessity in Dominican Theology at Oxford 1300-1350. She has now retired.
Professor Gelber received her Ph.D. in History from the University of Wisconsin in 1974 and has taught at Stanford since 1978, beginning as a part-time lecturer in Philosophy before moving to Religious Studies in 1982. -
Pascal Geldsetzer
Assistant Professor of Medicine (Primary Care and Population Health) and, by courtesy, of Epidemiology and Population Health
BioPascal Geldsetzer is an Assistant Professor of Medicine in the Division of Primary Care and Population Health and, by courtesy, in the Department of Epidemiology and Population Health. He is also affiliated with the Phil & Penny Knight Initiative for Brain Resilience at the Wu Tsai Neurosciences Institute, Department of Biomedical Data Science, Department of Health Policy, and the Stanford Center for Population Health Sciences.
His research focuses on identifying and evaluating the most effective interventions for improving health at older ages. In addition to leading several randomized trials, his methodological emphasis lies in the use of natural experiments to ascertain causal effects in large observational datasets, particularly in electronic health record data. He has won an NIH New Innovator Award (in 2022), a Chan Zuckerberg Biohub investigatorship (in 2022), and three NIH R01 grants as Principal Investigator (in 2023 and 2024). In 2026, he was named one of the 100 most influential people in health and medicine globally by TIME Magazine. -
Michele Gelfand
John H. Scully Professor of International Business Studies and Professor, by courtesy, of Psychology
BioMichele Gelfand is the John H. Scully Professor of Cross-Cultural Management and Professor of Organizational Behavior at the Stanford Graduate School of Business School and Professor of Psychology by Courtesy. She was formerly a Distinguished University Professor of Psychology at the University of Maryland, College Park. Gelfand uses field, experimental, computational and neuroscience methods to understand the evolution of culture and its multilevel consequences. Her work has been published in outlets such as Science, the Proceedings of the National Academy of Sciences, Psychological Science, Nature Human behavior, the Journal of Personality and Social Psychology, Journal of Applied Psychology, Academy of Management Journal, among others. Gelfand is the founding co-editor of the Advances in Culture and Psychology series (Oxford University Press). Her book Rule Makers, Rule Breakers: How Tight and Loose Cultures Wire the World was published by Scribner in 2018. She is the Past President of the International Association for Conflict Management and co-founder of the Society for the Study of Cultural Evolution. She received the 2016 Diener award from SPSP, the 2017 Outstanding International Psychologist Award from the American Psychological Association, the 2019 Outstanding Cultural Psychology Award from the Society for Personality and Social Psychology, the 2020 Rubin Theory-to-Practice award from the International Association of Conflict Management, the 2021 Contributions to Society award from the Organizational Behavior Division of the Academy of Management, and the Annaliese Research Award from the Humboldt Foundation. Gelfand was elected to the American Academy of Arts and Sciences in 2019 and the National Academy of Sciences in 2021.
-
Albert Gelpi
Coe Professor of American Literature, Emeritus
BioFULL NAME: Albert Joseph Gelpi
ACADEMIC ADDRESS: Department of English
Stanford University, Stanford CA 94305
HOME ADDRESS: 870 Tolman Drive, Stanford CA 94305
BIRTH: July 19, 1931, New Orleans, Louisiana
FAMILY: Married Barbara Charlesworth, June 14 1965
Children: Christopher, born 1966; Adrienne, born 1970
EDUCATION: A. B. Loyola University (New Orleans, 1951
M. A. Tulane University, 1956
Ph. D. Harvard University, 1962
ACADEMIC POSITIONS:
Assistant Professor, Harvard University, 1962-68
Head Tutor, Department of English, Harvard University, 1965-68
Associate Professor, Stanford University, 1968-74
Director of Graduate Studies, Department of English, Stanford, 1969-72, 1978-80
Professor, Stanford University, 1974-1999
William Robertson Coe Professor of American Literature, 1978-1999
Guggenheim Fellow, 1977-78
Vice Chair, Department of English, Stanford University, 1979-81, 1988-97
Chair, American Studies, Stanford University, 1976-77, 1989-90, 1994-97
Associate Dean of Graduate Studies & Research, Stanford University, 1980-85
Chair, Department of English, 1985-88
William Robertson Coe Professor of American Literature, emeritus, 1999—
PUBLISHED BOOKS:
Emily Dickinson: The Mind of the Poet, Harvard University Press, 1965, paperback W. W. Norton, 1971
The Poet in America, 1650 to the Present, D. C. Heath, 9173
Adrienne Rich’s Poetry (edited with Barbara Charlesworth Gelpi), W. W. Norton, 1973
The Tenth Muse: The Psyche of the American Poet, Harvard University Press, 1975; reissued with new introduction Cambridge University Press, 1991
Wallace Stevens: The Poetics of Modernism, Cambridge University Press, 1986
A Coherent Splendor: The American Poetic Renaissance 1910-1950, Cambridge University Press, 1987
Adrienne Rich’s Poetry and Prose (edited with Barbara Charlesworth Gelpi, W. W. Norton, 1992
Denise Levertov: Selected Criticism, University of Michigan Press, 1993
The Blood of the Poet: Selected Poems of William Everson, Broken Moon Press, 1994
Living in Time: The Poetry of C. Day Lewis, Oxford University Press, 1993
A Whole New Poetry Beginning Here: Adrienne Rich in the Eighties and Nineties (edited with Jacqueline Brogan), Women’s Studies, 1998
The Wild God of the World: An Anthology of Robinson Jeffers, Stanford University Press, 2003
Dark God of Eros: A William Everson Reader, Heyday Books, 2003
The Letters of Robert Duncan and Denise Levertov (edited with Robert J. Bertholf), Stanford University Press, 2004
Robert Duncan and Denise Levertov:The Poetry of Politics, the Politics of Poetry (edited with Robert J. Bertholf), Stanford University Press, 2006
American Poetry after Modernism: The Power of the Word, Cambridge: Cambridge University Press, 2015
C. Day-Lewis, The Golden Bridle: Selected Prose (edited with Bernard O’Donoghue) Oxford: Oxford University Press, 2017
Adrienne Rich: Poetry and Prose (edited with Barbara Charlesworth Gelpi &Brett Millier) New York: W. W. Norton, 2018
Adrienne Rich, Selectred Poems (edited with barbara Charlesworth Gelpi & Brett Millier) New York:W> W> Worton, 2018 -
Emily Geminder
Lecturer
BioEmily Geminder is the author of Dead Girls and Other Stories, winner of the Dzanc Books Short Story Prize. Her stories, poems, and essays have appeared in American Short Fiction, Conjunctions, Kenyon Review, New England Review, Tin House, and elsewhere. A former Stegner Fellow, she’s also received fellowships from Yaddo, the Center for Feminist Research, and others. She currently teaches creative writing at Stanford University.
-
Michael Genesereth
Associate Professor of Computer Science
BioGenesereth is most known for his work on Computational Logic and applications of that work in Enterprise Management, Computational Law, and General Game Playing. He is one of the founders of Teknowledge, CommerceNet, Mergent Systems, and Symbium. Genesereth is the director of the Logic Group at Stanford and the founder and research director of CodeX - the Stanford Center for Legal Informatics.
-
Linda N. Geng, MD, PhD
Clinical Associate Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsMy scholarly focus is on puzzling and complex conditions. Our work aims to improve patients' diagnostic journeys, characterize poorly understood diseases, discover biological mechanisms, find treatments, improve care models, and reach communities in need.
With the COVID pandemic, the puzzling and complex illness of Long COVID or post-acute COVID-19 syndrome (PACS) emerged. Together with a multidisciplinary group of physicians and researchers, we launched a program here at Stanford to advance the care and understanding of Long COVID. Our goal is to better understand the natural history, clinical symptomatology, immunological response, risk factors, and subtypes of Long COVID. We are also actively assessing treatment strategies for Long COVID and developing care pathways and tools for clinicians to help their patients with this and other related infection-associated chronic illnesses. -
Grace Gengoux, PhD, BCBA-D
Clinical Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
Current Research and Scholarly InterestsDr. Grace Gengoux is Director of the Autism Intervention Clinic and leads an autism intervention research program focused on developing and evaluating promising behavioral and developmental treatments for Autism Spectrum Disorder (ASD).
Dr. Gengoux is also Associate Chair for Faculty Engagement & Well-being and Department Well-being Director in the Department of Psychiatry and Behavioral Sciences, leading the department's Standing Well-being Advisory Committee. -
Mark Genovese
James W. Raitt M.D. Professor, Emeritus
Current Research and Scholarly InterestsClinical trials and interventions in the rheumatic diseases including Rheumatoid Arthritis,Systemic Lupus Erythematosus, Systemic Sclerosis, Osteoarthritis.
-
Michael Gensheimer
Clinical Associate Professor, Radiation Oncology - Radiation Therapy
Current Research and Scholarly InterestsIn addition to my clinical research in head and neck and lung cancer, I work on the application of computer science and machine learning to cancer research. I develop tools for analyzing large datasets to improve outcomes and safety of cancer treatment. I developed a machine learning prognostic model using data from around 13,000 patients with metastatic cancer which performs better than traditional models and physicians [PubMed ID 33313792]. We recently completed a prospective randomized study in thousands of patients in which the model was used to help improve advance care planning conversations.
I also work on the methods underpinning observational and predictive modeling research. My open source nnet-survival software that allows use of neural networks for survival modeling has been used by researchers internationally. In collaboration with the Stanford Research Informatics Center, I examined how electronic medical record (EMR) survival outcome data compares to gold-standard data from a cancer registry [PubMed ID 35802836]. The EMR data captured less than 50% of deaths, a finding that affects many studies being published that use EMR outcomes data. -
Andrew Gentles
Associate Professor (Research) of Pathology, of Medicine (Computational Medicine) and, by courtesy, of Biomedical Data Science
Current Research and Scholarly InterestsComputational systems biology
-
Paul George, MD, PhD
Associate Professor of Neurology and Neurological Sciences (Adult Neurology) and, by courtesy, of Neurosurgery
Current Research and Scholarly InterestsDEVELOPMENT OF STROKE RECOVERY THERAPEUTICS:
Stroke is devastating to patients and their caregivers. We currently are investigating 3 neural repair approaches. The first focuses on developing a stroke recovery therapeutic based on an essential repair pathway and how it alters the immune response following stroke. The second utilizes implantable, conductive polymer devices to electrically manipulate the recovering nervous system to improve recovery and identify novel therapeutic targets. The final approach works to optimize stem cell therapeutics to enhance their ability to treat patients who have suffered from neural injury.
CONDUCTIVE BIOPOLYMER SYSTEMS FOR NEURAL RECOVERY AND STEM CELL MODULATION:
The George lab develops biomaterials to improve neural recovery in the peripheral and central nervous systems. By controlled release of drugs and molecules through biomaterials we can study the temporal effect of these neurotrophic factors on neural recovery and engineer drug delivery systems to enhance regenerative effects. By identifying the critical mechanisms for neural recovery, we are able to develop polymeric technologies for clinical translation in nerve regeneration. Recent work utilizes these novel conductive polymers to differentiate stem cells for therapeutic and drug discovery applications.
APPLYING ENGINEERING TECHNIQUES TO DETERMINE BIOMARKERS FOR STROKE DIAGNOSTICS:
The ability to create diagnostic assays and techniques enables us to understand biological systems more completely and improve clinical management. Previous work utilized mass spectroscopy proteomics to find a simple serum biomarker for TIAs (a warning sign of stroke). Our study discovered a novel candidate marker, platelet basic protein. Current studies are underway to identify further candidate biomarkers using transcriptome analysis. More accurate diagnosis will allow for aggressive therapies to prevent subsequent strokes. -
Marios Georgiadis
Instructor, Radiology
BioMarios is an Instructor of Neuroimaging in the Department of Radiology.
His research focuses mainly on studying brain microstructure using cutting edge imaging (advanced X-ray, MRI, optical, and spatial biology approaches), with a particular focus on Alzheimer's disease hippocampi, neurodegeneration, and a special interest in myelin and iron.
He is also actively involved in projects related to imaging and modeling brain trauma, exosome signatures of neurodegeneration, and imaging the brain using advanced forms of electron and light microscopy.
His current research is being supported by NIH, the Alzheimer's Association, the American Society of Neuroradiology, the National Alzheimer's Coordinating Center (NACC), and the Stanford ADRC.
Marios is a mechanical engineer by training (School of Mechanical Engineering, National Technical University of Athens, Greece). His thesis "Closed-loop force control of a haptic surgical simulator", was performed in the Control Systems Lab of Prof. Evangelos Papadopoulos.
In 2011 he obtained his MSc in Biomedical Engineering from ETH Zurich (Swiss Federal Institute of Technology). He performed his thesis in IBM Research on "Advanced pathology using the Microfluidic Probe", under Emmanuel Delamarche and Govind Kaigala, and was awarded the ETH medal for this work.
He completed his PhD in Bone Biomechanics in the lab of Prof. Ralph Muller in ETH Zurich, where he developed X-ray scattering-based methods to investigate bone microstructure in 3D, research that earned him the 2nd Student Award from the European Society for Biomechanics in 2015.
In 2016 he started using imaging methods to study brain microstructure, in the lab of Prof. Markus Rudin, in the Institute for Biomedical Engineering of ETH Zurich. There, he combined X-ray scattering with DTI, histology and CLARITY for studying rodent brain.
In 2017 he joined the MRI Biophysics group of Profs. Els Fieremans and Dmitry Novikov in New York University School of Medicine, to study human and mouse brain microstructure using X-ray scattering and diffusion MRI.
He is in the Translational Neuroimaging lab, headed by Dr Michael Zeineh, since 2019.
His research on myelin in mouse and human brain using X-ray scattering has been supported twice by the Swiss National Science Foundation. -
Daniel Aaron Gerber, MD
Clinical Associate Professor, Medicine - Cardiovascular Medicine
BioDr. Gerber is a critical care cardiologist and medical director of Stanford's cardiac ICU. He has dual subspecialty training in cardiovascular and critical care medicine and additional board certification in echocardiography. He completed his residency in internal medicine, fellowship in cardiovascular medicine, and an additional fellowship in critical care medicine at Stanford University and joined as faculty in 2021 as a Clinical Assistant Professor in the Department of Medicine’s Division of Cardiovascular Medicine.
Dr. Gerber manages the full spectrum of heart and vascular conditions with a focus on critically ill patients with life-threatening cardiovascular disease. He is active in medical education, teaching introductory echocardiography to Stanford medical students and residents, co-directing the Stanford Critical Care Medicine Critical Care Ultrasound Program, and lecturing nationally on critical care echocardiography and point-of-care ultrasonography at the Society of Critical Care Medicine’s annual congress. Finally, Dr. Gerber’s research interests focus on optimizing cardiac intensive care, including working with the Critical Care Cardiology Trials Network (CCCTN) - a national network of tertiary cardiac ICUs coordinated by the TIMI Study Group - and studying acute mechanical circulatory support techniques to improve patient outcomes and care processes. -
J. Christian Gerdes
Professor of Mechanical Engineering, Emeritus
BioChris Gerdes is a Professor Emeritus of Mechanical Engineering at Stanford University. His laboratory studies how cars move, how humans drive cars and how to design future cars that work cooperatively with the driver or drive themselves. Vehicles in the lab include X1, a student-built electric, steer-by-wire test vehicle; Takumi, a modified Toyota Supra capable of autonomous drifting in tandem with another car; and Marty, the electrified, automated, drifting DeLorean. Chris' interests in vehicle safety extend to ethics and government policy, having helped to develop the US Federal Automated Vehicle Policy while serving as the first Chief Innovation Officer of the US Department of Transportation.
-
Yael Gernez
Clinical Associate Professor, Pediatrics - Immunology
BioMy clinic focuses on solving the molecular puzzles that underlie rare allergic and immunologic diseases to shed light on fundamental principles governing allergy, inflammation and immune system defects. My goal is to find better and safer therapies for my patients with rare diseases that include autoinflammation, autoimmunity and primary immune deficiency. It is important to highlight that every patient requires individualized therapeutic approaches based on their underlying genetic problem and the types and severity of their clinical manifestations. For some patients, a hematopoietic stem cell transplant (HSCT) is curative while for others, a targeted drug therapy, such as a biologic or small molecule agent, is most suitable. In some cases, a truly novel therapy may be required, .e.g., anti-sense oligonucleotide therapy to suppress aberrant gene splicing or adoptive cellular therapy. My passion is to provide the best personalized therapy for our patients with allergy and immunology diseases. This often requires performing very specialized functional assays and in some cases in enlisting laboratories with specific expertise or interest in particular genetic disorders.
